<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; diving</title>
	<atom:link href="http://www.tapanray.in/tag/diving/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>With ‘Cutting Corners’ Going North, Pharma Reputation Dives South</title>
		<link>http://www.tapanray.in/with-cutting-corners-going-north-pharma-reputation-dives-south/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=with-cutting-corners-going-north-pharma-reputation-dives-south</link>
		<comments>http://www.tapanray.in/with-cutting-corners-going-north-pharma-reputation-dives-south/#comments</comments>
		<pubDate>Mon, 15 Jan 2018 00:00:57 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[campaign]]></category>
		<category><![CDATA[Corners]]></category>
		<category><![CDATA[cut]]></category>
		<category><![CDATA[cutting]]></category>
		<category><![CDATA[diving]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[George W. Merck]]></category>
		<category><![CDATA[group]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Lobby]]></category>
		<category><![CDATA[north]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[practices]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rejuvenation]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[Self]]></category>
		<category><![CDATA[serving]]></category>
		<category><![CDATA[South]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8735</guid>
		<description><![CDATA[Just a few months ago, on October 24, 2017, ‘New Jersey Law Journal’ came out with an eye-catching headline &#8211; “Sanofi Set to Pay $ 61M Settlement in Antitrust Suit Over Vaccine Bundling.” The suit says: &#8220;Sanofi-Pasteur allegedly suppressed competition &#8230; <a href="http://www.tapanray.in/with-cutting-corners-going-north-pharma-reputation-dives-south/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/with-cutting-corners-going-north-pharma-reputation-dives-south/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
